This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Sandbox Reserved 1160
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
== Human metabotropic glutamate receptor 5 transmembrane domain == | == Human metabotropic glutamate receptor 5 transmembrane domain == | ||
<StructureSection load='4oo9' size='350' frame='true' side='right' caption='Human metabotropic glutamate receptor 5 transmembrane domain' <'scene='(Ionic_lock)'> | <StructureSection load='4oo9' size='350' frame='true' side='right' caption='Human metabotropic glutamate receptor 5 transmembrane domain' <'scene='(Ionic_lock)'> | ||
| - | The human metabotropic glutamate receptor 5 transmembrane domain is a homodimeric | + | The human metabotropic glutamate receptor 5 transmembrane domain is a homodimeric GPCR that resides in the cellular membrane. This domain is a member of the Class C GPCR family and can further be categorized into the Group I subgroup. As such, the transmembrane domain will signal through a Gq/11 pathway. mGlu5 will bind glutamate to the extracellular Venus flytrap domain and the signal will be transduced across the membrane to a heterotrimeric G protein, which will ultimately lead to calcium release and activation of PKC. Human metabotropic glutamate receptor 5 is found throughout the central nervous system. Areas containing high concentrations of this protein are often involved involved in emotions and higher cognition. This makes mGlu5 a possible target for treating schizophrenia, Fragile X, depression, anxiety,and Alzheimer's disease. |
== Discovery == | == Discovery == | ||
Revision as of 23:51, 28 March 2016
Human metabotropic glutamate receptor 5 transmembrane domain
| |||||||||||
